<DOC>
	<DOCNO>NCT00945425</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability repeat ascend dos AZD7325 Japanese healthy male subject .</brief_summary>
	<brief_title>AZD7325 Japan Multiple Ascending Dose ( MAD ) Study</brief_title>
	<detailed_description />
	<criteria>Japanese subject Significant illness , judge investigator , within 2 week Day 1 Enrollment another concurrent investigational study intake investigational drug within 4 month prior screen visit Blood loss excess 200 mL within 30 day Day 1 , excess 400 mL within 90 day Day 1 , excess 1200 mL within 1 year Day 1 Clinically relevant abnormality physical examination , vital sign , clinical chemistry , hematology urinalysis judge investigator and/or sponsor</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Phase I</keyword>
	<keyword>Volunteer</keyword>
</DOC>